Why American Authorities Should Consider a Temporary Recommendation for Use of Baclofen in the Treatment of Alcohol Use Disorder

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Last Modified
  • April 6, 2020
Creator
  • Chedaille, Philippe
    • Affiliation: Gillings School of Global Public Health, Public Health Leadership Program
Abstract
  • The existing literature disagrees in terms of treatment options and alternatives for individuals dealing with Alcohol Use Disorder (AUD), but agree on the need to solve this public health concern. This paper seeks to first understand the disease and the drugs available for its treatment and secondly reviews the guidelines and regulations that either restrict or encourage the market authorization (MA) of a drug. Those will be the foundations for suggesting the implementation of a temporary recommendation for use of the Baclofen in the treatment of AUD. A review of positive and negative outcomes from peer-reviewed Randomized Controlled Trials (RCT) is provided to demonstrate Baclofen's success in the treatment of AUD and support the implementation of a temporary recommendation for use (TRU) in the United States.
Date of publication
DOI
Resource type
Rights statement
  • In Copyright
Note
  • Track: Leadership
  • Paper type: Policy
Advisor
  • Evarts, Lori
Reviewer
  • Thorp, John
Degree
  • Master of Public Health
Degree granting institution
  • University of North Carolina at Chapel Hill
Graduation year
  • 2015
Language
Deposit record
  • 5b7bbb8c-0f2d-4eef-820e-89b306693a97

Relations

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details Chedaille_Master_Paper.pdf 2020-04-06 Public Download